Singapore Medical Group has its heart set on regional growth
The group aims to strengthen its foothold abroad, albeit with cautious optimism, especially in Australia, Vietnam and Indonesia.
OPPORTUNITIES abound beyond Singapore's shores, and specialist healthcare provider Singapore Medical Group (SMG) is raring to go.
Even as it continues to grow its domestic business across the Republic's heartlands, the Catalist-listed company is hungry for further expansion and new ventures in the Asia-Pacific.
"We're one of the few Singapore healthcare companies that have been actively investing and growing our overseas footprint. From that standpoint, we're extremely unique," says Beng Teck Liang, SMG's chief executive officer and executive director.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
UBS weighs synthetic risk transfer amid capital boost proposals
Oil settles higher on supply concerns in the Mid-East, economic woes subdue gains
S-Reits falter as investors weigh possibility of zero rate cuts in 2024
CapitaLand Investment posts total revenue of S$650 million for Q1
Europe: Stoxx 600 logs best day in three months as banks shine
US: Stocks rally after strong tech results